Results 111 to 120 of about 27,151,543 (398)
Enhanced vaccine control of epidemics in adaptive networks [PDF]
, 2009 We study vaccine control for disease spread on an adaptive network modeling disease avoidance behavior. Control is implemented by adding Poisson distributed vaccination of susceptibles.
Ira B. Schwartz +4 more
core +3 more sources
Circulating histones as clinical biomarkers in critically ill conditions
FEBS Letters, EarlyView.Circulating histones are emerging as promising biomarkers in critical illness due to their diagnostic, prognostic, and therapeutic potential. Detection methods such as ELISA and mass spectrometry provide reliable approaches for quantifying histone levels in plasma samples.
José Luis García‐Gimenez +17 more
wiley +1 more source
Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel Disease [PDF]
, 2016 OBJECTIVES:Autoimmune liver disease is reported in up to 7.8% of children with inflammatory bowel disease. A distinct inflammatory bowel disease phenotype has been suggested in adults and in small pediatric cohorts.
Alexopoulou +31 more
core +1 more source
Journal of Veterinary Research, 2020 Three strains of the FMD virus (A, O, and SAT 2) were recognised as causes of the FMD circulating in Egypt. The aims of this study were to trace the FMDV isolates from outbreaks in Egypt to understand their epidemiology and evolution and to understand ...
El Nahas Abeer F., Salem Sayed A.H.
doaj +1 more source
FEBS Letters, EarlyView.This study reveals how prime editing guide RNA (pegRNA) secondary structure and reverse transcriptase template length affect prime editing efficiency in correcting the phospholamban R14del cardiomyopathy‐associated mutation. Insights support the design of structurally optimized enhanced pegRNAs for precise gene therapy.
Bing Yao +7 more
wiley +1 more source
COPD and cardiovascular disease [PDF]
, 2019 COPD is one of the major public health problems in people aged 40 years or above. It is currently the 4th leading cause of death in the world and projected to be the 3rd leading cause of death by 2020.
André, S. +5 more
core +3 more sources
H3Africa: current perspectives
Pharmacogenomics and Personalized Medicine, 2018 Nicola Mulder,1 Alash’le Abimiku,2 Sally N Adebamowo,3 Jantina de Vries,4 Alice Matimba,5 Paul Olowoyo,6 Michele Ramsay,7 Michelle Skelton,1 Dan J Stein8,9 On behalf of the members of the H3Africa Consortium 1Computational Biology Division ...
Mulder N +8 more
doaj
Social Change Review, 2014 The aim of this paper is to analyse the sociological literature on pharmaceuticalisation and see how sociology helps us understand and explain the phenomenon.
Bordogna Mara Tognetti
doaj +1 more source